DrugPatentWatch Database Preview
Physiological Effect: Vasodilation
» See Plans and Pricing
Drugs with Physiological Effect: Vasodilation
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Arbor Pharms Llc | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Auxilium Pharms Llc | DILATRATE-SR | isosorbide dinitrate | CAPSULE, EXTENDED RELEASE;ORAL | 019790-001 | Sep 2, 1988 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Teva Pharms Usa | EPOPROSTENOL SODIUM | epoprostenol sodium | INJECTABLE;INJECTION | 078396-001 | Apr 23, 2008 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |